BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 31718550)

  • 21. The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease.
    Wright PB; McDonald E; Bravo-Blas A; Baer HM; Heawood A; Bain CC; Mowat AM; Clay SL; Robertson EV; Morton F; Nijjar JS; Ijaz UZ; Milling SWF; Gaya DR
    Sci Rep; 2021 Oct; 11(1):19616. PubMed ID: 34608184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.
    Hartog A; Belle FN; Bastiaans J; de Graaff P; Garssen J; Harthoorn LF; Vos AP
    J Nutr Biochem; 2015 Mar; 26(3):227-33. PubMed ID: 25498760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
    Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
    Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease.
    Dige A; Magnusson MK; Öhman L; Hvas CL; Kelsen J; Wick MJ; Agnholt J
    Scand J Gastroenterol; 2016; 51(6):692-9. PubMed ID: 26784676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation.
    Magnusson MK; Brynjólfsson SF; Dige A; Uronen-Hansson H; Börjesson LG; Bengtsson JL; Gudjonsson S; Öhman L; Agnholt J; Sjövall H; Agace WW; Wick MJ
    Mucosal Immunol; 2016 Jan; 9(1):171-82. PubMed ID: 26080709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis.
    Ismahil MA; Hamid T; Bansal SS; Patel B; Kingery JR; Prabhu SD
    Circ Res; 2014 Jan; 114(2):266-82. PubMed ID: 24186967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond macrophages: the diversity of mononuclear cells in tuberculosis.
    Srivastava S; Ernst JD; Desvignes L
    Immunol Rev; 2014 Nov; 262(1):179-92. PubMed ID: 25319335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology.
    Aychek T; Mildner A; Yona S; Kim KW; Lampl N; Reich-Zeliger S; Boon L; Yogev N; Waisman A; Cua DJ; Jung S
    Nat Commun; 2015 Mar; 6():6525. PubMed ID: 25761673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
    Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
    Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples.
    Boros É; Prontvai B; Kellermayer Z; Balogh P; Sarlós P; Vincze Á; Varga C; Maróti Z; Bálint B; Nagy I
    Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32610492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease.
    Ortega Moreno L; Fernández-Tomé S; Chaparro M; Marin AC; Mora-Gutiérrez I; Santander C; Baldan-Martin M; Gisbert JP; Bernardo D
    Inflamm Bowel Dis; 2021 Jan; 27(2):268-274. PubMed ID: 32548643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response.
    Correale C; Genua M; Vetrano S; Mazzini E; Martinoli C; Spinelli A; Arena V; Peyrin-Biroulet L; Caprioli F; Passini N; Panina-Bordignon P; Repici A; Malesci A; Rutella S; Rescigno M; Danese S
    Gastroenterology; 2013 Feb; 144(2):346-356.e3. PubMed ID: 23108068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease.
    Eri R; Kodumudi KN; Summerlin DJ; Srinivasan M
    Inflamm Bowel Dis; 2008 Apr; 14(4):458-70. PubMed ID: 18186109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid recruitment of CD14(+) monocytes in experimentally induced allergic rhinitis in human subjects.
    Eguíluz-Gracia I; Bosco A; Dollner R; Melum GR; Lexberg MH; Jones AC; Dheyauldeen SA; Holt PG; Bækkevold ES; Jahnsen FL
    J Allergy Clin Immunol; 2016 Jun; 137(6):1872-1881.e12. PubMed ID: 26851967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.
    Uzzan M; Colombel JF; Cerutti A; Treton X; Mehandru S
    Dig Dis Sci; 2016 Dec; 61(12):3407-3424. PubMed ID: 27655102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.
    Hsu P; Choi EJ; Patel SA; Wong WH; Olvera JG; Yao P; Liu YC; Tsai MS; Wang W; Boland BS; Chang JT
    Inflamm Bowel Dis; 2023 Oct; 29(10):1602-1612. PubMed ID: 37235748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells.
    Zigmond E; Varol C; Farache J; Elmaliah E; Satpathy AT; Friedlander G; Mack M; Shpigel N; Boneca IG; Murphy KM; Shakhar G; Halpern Z; Jung S
    Immunity; 2012 Dec; 37(6):1076-90. PubMed ID: 23219392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.